We evaluated the efficacy and safety of vagus nerve stimulation and safety of vagus nerve stimulation therapyin the treatmentof11patients with therapyinthe treatment of11patients with chronic treatment-resistant depression. chronic treatment-resistant depression. Mood was evaluated at frequent intervals Mood was evaluated at frequent intervals over the year following implantation. All over the year following implantation. All measures of depression, including the measures of depression, including the Hamilton Rating Scale for Depression Hamilton Rating Scale for Depression reduced significantly.The response and reduced significantly.The response and remission rates were 55% and 27% remission rates were 55% and 27% respectively at1year. Side-effects were respectively at1year. Side-effects were common, and some were severe. common, and some were severe.
Major depressive disorder is one of the Major depressive disorder is one of the leading causes of morbidity in the world leading causes of morbidity in the world (Ustun (Ustun et al et al, 2004) . Chronicity, where , 2004) . Chronicity, where there is ongoing unremitted major depresthere is ongoing unremitted major depression for at least a 2-year period, occurs sion for at least a 2-year period, occurs in approximately 2.1% of the world popuin approximately 2.1% of the world population and is associated with severe impairlation and is associated with severe impairment in psychosocial functioning (Scott, ment in psychosocial functioning (Scott, 2000) . Vagus nerve stimulation therapy 2000). Vagus nerve stimulation therapy has been found to be an effective treatment has been found to be an effective treatment for the management of resistant epilepsy for the management of resistant epilepsy and to be efficacious in some trials and to be efficacious in some trials involving individuals with treatmentinvolving individuals with treatmentresistant depression (George resistant depression (George et al et al, 2000) . , 2000). The aim of this study was to evaluate the The aim of this study was to evaluate the safety and efficacy of vagus nerve stimulasafety and efficacy of vagus nerve stimulation therapy in 11 patients with chronic tion therapy in 11 patients with chronic treatment-resistant depression. treatment-resistant depression.
METHOD METHOD

Participants and setting Participants and setting
Patients were recruited from Beaumont Patients were recruited from Beaumont Hospital, Dublin. This centre was part of Hospital, Dublin. This centre was part of the European safety and efficacy study the European safety and efficacy study for vagus nerve stimulation therapy in for vagus nerve stimulation therapy in treatment-resistant depression (D-03). treatment-resistant depression (D-03). Patients were eligible for inclusion if they Patients were eligible for inclusion if they fulfilled criteria for major depressive disfulfilled criteria for major depressive disorder, suffered from a chronic ( order, suffered from a chronic (4 42 years) 2 years) current episode, scored current episode, scored 5 520 on the 20 on the Hamilton Rating Scale for Depression Hamilton Rating Scale for Depression (HRSD; Hamilton, 1960) and had failed (HRSD; Hamilton, 1960) and had failed to respond to antidepressants from at to respond to antidepressants from at least two different categories. Major least two different categories. Major depressive disorder was diagnosed using depressive disorder was diagnosed using the Structured Clinical Interview for the Structured Clinical Interview for DSM-IV (First DSM-IV (First et al et al, 1996) , and was , 1996), and was measured using multiple scales including measured using multiple scales including the HRSD and the Inventory of Depressive the HRSD and the Inventory of Depressive Symptomatology -Subjective Rating (Rush Symptomatology -Subjective Rating (Rush et al et al, 1986) . Ethical approval was obtained , 1986). Ethical approval was obtained locally. All patients gave fully informed locally. All patients gave fully informed written consent and were made aware of written consent and were made aware of all potential complications. all potential complications.
Surgical procedure Surgical procedure
The neurosurgical team, led by J.P. imThe neurosurgical team, led by J.P. implanted the NeuroCybernetic Prosthesis planted the NeuroCybernetic Prosthesis system (Cyberonics Europe, Belgium system (Cyberonics Europe, Belgium) ) surgically. This procedure involves the surgically. This procedure involves the subcutaneous implantation, under general subcutaneous implantation, under general anaesthetic, of a pacemaker-like device into anaesthetic, of a pacemaker-like device into the left axillary area of the chest, with a the left axillary area of the chest, with a bipolar lead tracking from there to the cerbipolar lead tracking from there to the cervical vagus nerve. The device operates by vical vagus nerve. The device operates by discharging a small fixed electrical signal discharging a small fixed electrical signal of 30 s duration every 5 min to the vagus of 30 s duration every 5 min to the vagus nerve. nerve.
Study design Study design
There were two periods under study: an There were two periods under study: an acute phase (12 weeks), commencing from acute phase (12 weeks), commencing from 2 weeks after implantation, and a long-2 weeks after implantation, and a longterm phase of stimulation administration term phase of stimulation administration (40 weeks). For the first 2 weeks of (40 weeks). For the first 2 weeks of the acute phase vagus stimulation was the acute phase vagus stimulation was adjusted, and thereafter remained fixed adjusted, and thereafter remained fixed until week 12. Participants were evaluated until week 12. Participants were evaluated at weekly or 2-weekly intervals during this at weekly or 2-weekly intervals during this phase, and thereafter had follow-up evaluphase, and thereafter had follow-up evaluation at 6, 9 and 12 months. A combined ation at 6, 9 and 12 months. A combined total of five antidepressants and mood total of five antidepressants and mood stabilisers were allowed as long as the stabilisers were allowed as long as the individual had been stable on these mediindividual had been stable on these medications for 4 weeks before the initial visit. cations for 4 weeks before the initial visit. Patients were considered protocol violators Patients were considered protocol violators if their antidepressant medications were if their antidepressant medications were changed during the acute phase. However, changed during the acute phase. However, alterations in psychotropic medication alterations in psychotropic medication were allowed during the long-term phase. were allowed during the long-term phase.
Statistical analysis Statistical analysis
One-way analysis of variance of outcome One-way analysis of variance of outcome measures over time was performed. measures over time was performed. PostPosthoc hoc analysis was used to examine differanalysis was used to examine differences in scores over the specific time points. ences in scores over the specific time points. Response was defined as a Response was defined as a 5 550% decrease 50% decrease in the HRSD from the baseline HRSD in the HRSD from the baseline HRSD scores. Remission was defined as HRSD scores. Remission was defined as HRSD score score 5 510. 10.
RESULTS RESULTS
All participants were White, with a mean All participants were White, with a mean age of 43 (s.d. age of 43 (s.d.¼8.72) years, and 73% were 8.72) years, and 73% were female. Overall, patients had a long history female. Overall, patients had a long history of depression with a mean length of illness of depression with a mean length of illness of 20 (s.d. of 20 (s.d.¼8.34) years. They had a median 8.34) years. They had a median episode duration of 46 months; only 2 episode duration of 46 months; only 2 had not had a previous episode. Electrohad not had a previous episode. Electroconvulsive therapy (ECT) had been received convulsive therapy (ECT) had been received by 55%. by 55%. One-way analysis of variance (ANOVA) between the depression scores over the time points. * One-way analysis of variance (ANOVA) between the depression scores over the time points. *Post-hoc Post-hoc P P5 50.05 0.05 compared with the score at 12 months. compared with the score at 12 months.
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Clinical outcomes Clinical outcomes
All measures of depression were statistically All measures of depression were statistically reduced at 1 year compared with baseline reduced at 1 year compared with baseline (Table 1) . There was one responder at 3 (Table 1 ). There was one responder at 3 months, two responders at 6 months and months, two responders at 6 months and 6 responders at 1 year. Three patients had 6 responders at 1 year. Three patients had remitted (defined as HRSD-24 remitted (defined as HRSD-245 510) by 1 10) by 1 year. Covarying for medications added year. Covarying for medications added during the study period did not result in during the study period did not result in any loss of statistical significance any loss of statistical significance ( (F F (39,4) (39,4)¼6.5, 6.5, P P5 50.001). 0.001). There were several serious adverse There were several serious adverse events. Patient 1, a treatment non-responder, events. Patient 1, a treatment non-responder, died by suicide at 9 months following died by suicide at 9 months following implantation, but had not revealed this implantation, but had not revealed this intention verbally. Patient 2 experienced a intention verbally. Patient 2 experienced a number of recurrences of pulmonary emboli number of recurrences of pulmonary emboli that first occurred following surgery that first occurred following surgery unrelated to the vagus nerve stimulation unrelated to the vagus nerve stimulation therapy. Patients 3 and 4 developed vocal therapy. Patients 3 and 4 developed vocal cord palsies of mixed duration following cord palsies of mixed duration following surgery; the palsy of patient 3 lasted for surgery; the palsy of patient 3 lasted for approximately 2 months, and that of approximately 2 months, and that of patient 4 approximately 6 months. There patient 4 approximately 6 months. There was a consequent delay in initiating treatwas a consequent delay in initiating treatment (i.e. the device was not switched on) ment (i.e. the device was not switched on) until symptom resolution. Both patients until symptom resolution. Both patients made a full recovery from the palsy. made a full recovery from the palsy.
DISCUSSION DISCUSSION
This study suggests that vagus nerve stimuThis study suggests that vagus nerve stimulation may be an effective treatment for lation may be an effective treatment for some individuals suffering from chronic some individuals suffering from chronic treatment-resistant depression. The retreatment-resistant depression. The response rates for the acute phase of the study sponse rates for the acute phase of the study were disappointing, in that only one patient were disappointing, in that only one patient responded after 3 months. By 1 year, 55% responded after 3 months. By 1 year, 55% of the sample had responded to treatment, of the sample had responded to treatment, suggesting that long-term follow-up is suggesting that long-term follow-up is required to realise the therapeutic potential required to realise the therapeutic potential of vagus nerve stimulation treatment. The of vagus nerve stimulation treatment. The placebo response in these patients was placebo response in these patients was typically poor and so probably does not typically poor and so probably does not account for the response rate (Stewart account for the response rate (Stewart et et al al, 1993) . , 1993). There was a striking number of adverse There was a striking number of adverse events in this study. It could be reasonably events in this study. It could be reasonably argued that the suicide was unrelated to argued that the suicide was unrelated to the treatment, except insofar as treatment the treatment, except insofar as treatment was ineffective, seeing that patient 1 left a was ineffective, seeing that patient 1 left a suicide note explaining her intention before suicide note explaining her intention before treatment to kill herself if the therapy did treatment to kill herself if the therapy did not cure her depression. It is more likely not cure her depression. It is more likely that the pulmonary emboli that were that the pulmonary emboli that were experienced by patient 2 were related to experienced by patient 2 were related to her cancer or antipsychotic medication, her cancer or antipsychotic medication, rather than the vagus nerve stimulation. rather than the vagus nerve stimulation. The vocal cord palsies experienced by The vocal cord palsies experienced by patients 3 and 4 (18% of the sample) would patients 3 and 4 (18% of the sample) would appear to be an idiosyncratic finding: appear to be an idiosyncratic finding: although this is a direct consequence of although this is a direct consequence of the surgical procedure, it usually only the surgical procedure, it usually only occurs in 1% of cases both internationally occurs in 1% of cases both internationally (George (George et al et al, 2000) , and within the study , 2000), and within the study hospital, where 50 such procedures are hospital, where 50 such procedures are performed annually. performed annually.
The findings from our trial are in The findings from our trial are in keeping with previous observations of a keeping with previous observations of a response rate of 40% over a period of response rate of 40% over a period of at least 1 year with vagus nerve stimulation at least 1 year with vagus nerve stimulation treatment for major depressive disorder, treatment for major depressive disorder, suggesting that adequate time should be suggesting that adequate time should be allowed before conclusions can be reached allowed before conclusions can be reached about clinical efficacy (Marangell about clinical efficacy (Marangell et al et al, , 2002 (Marangell et al et al, , ). 2002 .
Current physical treatment approaches Current physical treatment approaches to resistant depression include ECT to resistant depression include ECT (Folkerts (Folkerts et al et al, 1997) and psychosurgery , 1997) and psychosurgery (Bridges (Bridges et al et al, 1994) . ECT has a high inci-, 1994). ECT has a high incidence of reported adverse side-effects (UK dence of reported adverse side-effects (UK ECT Review Group, 2003) . Psychosurgery ECT Review Group, 2003) . Psychosurgery by its very nature will always be a treatby its very nature will always be a treatment of last resort. It has been reported that ment of last resort. It has been reported that 63% of patients receiving psychosurgery in 63% of patients receiving psychosurgery in the UK for resistant depression are the UK for resistant depression are markedly improved as a result (Royal markedly improved as a result (Royal College of Psychiatrists, 2002) . Deep brain College of Psychiatrists, 2002) . Deep brain stimulation therapy has been reported to stimulation therapy has been reported to be effective in 4 out of 6 cases of resistant be effective in 4 out of 6 cases of resistant depression (Mayberg depression (Mayberg et al et al, 2005) . , 2005).
Limitations Limitations
The main limitations of this study were that The main limitations of this study were that it was an open study, and patients were not it was an open study, and patients were not randomised to active or sham treatment. It randomised to active or sham treatment. It was not possible for raters to be masked was not possible for raters to be masked because of surgical scarring. In addition, because of surgical scarring. In addition, the sample size was small. Medication the sample size was small. Medication changes were allowed during the long-term changes were allowed during the long-term phase of the study, possibly impacting on phase of the study, possibly impacting on the findings, although we controlled for this the findings, although we controlled for this statistically. statistically.
